Press release
Migraine Therapeutics Market Growth Factors, Segmentation, Trends, Opportunities, Key Players and Forecast | Evolve Business Intelligence
• The global Migraine Therapeutics Market size was valued at USD 1.8 billion in 2022 growing at a CAGR of 3.15% from 2023 to 2033.
• Asia Pacific dominated the market in 2022
• North America is expected to grow at the highest CAGR from 2023 to 2033
As per the study initiated by Evolve Business Intelligence, the global Migraine Therapeutics Market size accounted for USD 1.8 billion in 2022, growing at a CAGR of 3.15% from 2023 to 2033. The migraine therapeutics market refers to the pharmaceutical industry segment dedicated to the development and sale of medications specifically designed to treat migraines. It encompasses a range of drugs, including acute and preventive treatments, aiming to alleviate the symptoms and reduce the frequency of migraine attacks. Key players in the market focus on research and development to introduce innovative therapies, such as calcitonin gene-related peptide (CGRP) inhibitors. The market's growth is driven by the increasing prevalence of migraines, rising awareness, and a demand for more effective and targeted treatment options for this neurological
disorder.
Request/Download PDF Sample: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021648
The migraine therapeutics market is primarily propelled by the growing prevalence of migraines worldwide. Increased awareness of migraine as a debilitating neurological condition and a rising demand for advanced and targeted treatment options contribute to market growth. Ongoing research and development, particularly in the field of CGRP inhibitors, play a crucial role in introducing innovative therapies, further driving the market.
Key Players
Some of the major Migraine Therapeutics Market players holding high market shares include Sanofi SA, Abbott Laboratories, Teva Pharmaceutical Industries Limited and Allergan Plc.These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders. Some of the other major market players include Pfizer Inc, AstraZeneca, Johnson & Johnson, Endo International Plc, GlaxoSmithKline Plc, Impax Laboratories.
Report Description: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021648
Segmental Analysis
Based on type, the Migraine Therapeutics market is segmented into Episodic and Chronic. In terms of revenue from the migraine market, the Episodic category retained a dominant position in 2022. For people who get one or two headaches a month, nonsteroidal anti-inflammatory medicines (NSAIDs) are prescribed and taken as soon as a migraine appears.
Based on Treatment Type, the Migraine Therapeutics market is segmented into Preventive and Abortive. The market was dominated by the Abortive sector in 2022, and during the forecast period of 2022-2030, it is anticipated to increase at a quicker rate.
Based on Drug Class, the Migraine Therapeutics market is segmented into Triptans, Ergots, and Others. Triptans held a dominant market position in 2022 and are anticipated to increase at the fastest rate throughout the 2022-2030 forecast period.
Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, BeNeLux, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Rest of Asia Pacific)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)
• Latin America (Mexico, Brazil, Argentina, Rest of Latin America)
Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/
About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune's global 2000 companies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Migraine Therapeutics Market Growth Factors, Segmentation, Trends, Opportunities, Key Players and Forecast | Evolve Business Intelligence here
News-ID: 3306167 • Views: …
More Releases from Evolve Business Intelligence
Plant-Based Meat Market Forecast to Reach USD 26.98 Billion by 2033
The plant-based meat market is at a pivotal point, marked by strong growth in the past decade but now facing headwinds. While traditional retail channels have seen recent slowdowns, the non-store-based segment, which includes direct-to-consumer (D2C) e-commerce, meal kits, and food service, presents a significant and largely untapped opportunity. This channel allows brands to bypass the challenges of traditional retail, such as intense competition for shelf space and high listing…
Nuclear Power Plant Market Forecast to Reach USD 40.75 Billion by 2033
As the world seeks a clean, reliable, and sustainable energy future, High Temperature Gas-Cooled Reactors (HTGRs) are emerging as a prime candidate to lead the next generation of nuclear power. This advanced reactor technology, which uses a graphite-moderated core and inert helium coolant, offers a unique blend of inherent safety and versatility that extends well beyond traditional electricity generation. While challenges remain, the opportunity for HTGRs to transform the nuclear…
LED Lighting Market Forecast to Reach USD 255.92 Billion by 2035
The global LED lighting market is on a trajectory of significant expansion, fueled by the rising demand for energy-efficient and sustainable lighting solutions. While the market for LED lamps remains strong, luminaires-complete lighting fixtures with integrated LEDs-are emerging as the primary driver of future growth. Valued at an estimated USD 71.59 billion in 2023, the market is projected to surge to over USD 255.92 billion by 2035, with a compound…
Sensor Market Forecast to Reach USD 457.26 Billion by 2032
The global sensor market is at a pivotal point, poised for remarkable growth driven by the proliferation of smart devices, industrial automation, and the Internet of Things (IoT). The market, valued at an estimated USD 241.06 billion in 2024, is projected to expand significantly to approximately USD 457.26 billion by 2032, demonstrating a robust Compound Annual Growth Rate (CAGR) of about 8.5%. Within this dynamic landscape, a key player is…
More Releases for Migraine
Leading Growth Driver in the Migraine Market Share in 2025: Rising Prevalence Of …
What Market Share dynamics are playing a key role in accelerating the growth of the migraine Market Share?
The migraine Market Share is projected to grow, driven by the rising occurrence of migraines. Migraines, a kind of headache that typically affects one side of the brain and causes intense, throbbing pain or a pulsing sensation, can be managed and relief can be provided via proper treatment. This treatment paves the way…
Emerging Acute Migraine Treatment Market Trend 2025-2034: Innovative CGRP Recept …
How Is the Acute Migraine Treatment Market Projected to Grow, and What Is Its Market Size?
The market size for acute migraine treatment has witnessed substantial growth in the past few years. Forecasts expect it to expand from $2.6 billion in 2024 to $2.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth in the historical period include the rising incidence of migraines,…
Key Influencer in the Migraine Market 2025: Rising Prevalence Of Migraine Drives …
"What Is the Forecasted Market Size and Growth Rate for the Migraine Market?
The migraine market is projected to grow steadily from $1.93 billion in 2024 to $1.97 billion in 2025, at a CAGR of 2.2%. This growth is attributed to the rising prevalence of migraines, growing awareness of treatment options, government initiatives, increased alcohol consumption, and lifestyle changes.
Migraine Market: Expected to grow to $2.25 billion by 2029 at a CAGR…
How Big is Migraine Drugs Market?
In 2022, the Global Migraine Drugs Market soared to USD 10,972.1 million, marking a significant milestone. Projections indicate a promising trajectory, with expectations set for substantial growth, potentially reaching USD 26,618.96 million by 2031. Forecasts for the period between 2024 and 2031 suggest a robust Compound Annual Growth Rate (CAGR) of 12.1% for the migraine drugs market.
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive…
Migraine Therapeutics Market - Relieve the Burden: Empowering Lives through Migr …
Newark, New Castle, USA - new report, titled Migraine Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Migraine Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Migraine Therapeutics market. The report offers an overview of the market, which…
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases.
The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs.
Get Access to TOC /…
